4 results
The main objective is to determine in what optimal dose PTX should be used in preterm infants suffering from sepsis. Previous clinical studies have already indicated the safety of the drug in preterm infants.
The aim of the current project is to evaluate the effect of a prosthetic foot, which can be individually optimized using human in the loop optimization, on metabolic cost of walking for transtibial amputees. We want to investigate both the effect of…
Long-term safety and pharmacokinetics (PK) of neoGAA
The overall objective is to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in male and femaleparticipants less than or equal to 6 months of age with IOPD.